| Outcome Measures: |
Primary: Change in Glycosylated hemoglobin A1c (HbA1c), percentage-points, From randomization to year 1 | Secondary: Patient achieving HbA1c below 7.0% (Yes /No), Count of patient(s), Year 1|Patient achieving HbA1c below or equal to 6.5% (Yes/No), Count of patient(s), Year 1|Patient achieving HbA1c below 7.0% or at least 1.0%-point reduction in HbA1c (Yes/No), Count of patient(s), From randomization to year 1|Patient achieving greater than or equal to 5% reduction in body weight (Yes/No), Count of patient(s), From randomization to year 1|Patient achieving individualized HbA1c target per Healthcare Effectiveness Data and Information Set (HEDIS) criteria (below 8.0% if age greater than or equal to 65 years or with defined comorbidities or otherwise below 7.0%) (Yes/No), Count of patient(s), Year 1|Patient achieving HbA1c less than or equal to treatment provider defined individualized target (Yes/No), Count of patient(s), Year 1|Relative change in body weight (%), Percentage, From randomization to year 1|Change in body weight (lbs), Lbs, From randomization to year 1|Time to treatment intensification (add-on) or change (switch), Days, From randomization to year 1|Diabetes Treatment Satisfaction Questionnaire, change version (DTSQc), Relative treatment satisfaction total score, Score on a scale (The Diabetes Treatment Satisfaction Questionnaire change version (DTSQc) will be used to measure the change in patient satisfaction with their diabetes treatment. It consists of a six-item scale assessing treatment satisfaction and two items assessing perceived frequency of hyperglycaemia and hypoglycaemia. The DTSQc items are on a scale from 3 to -3. If they experience no change, then 0 is chosen. Higher score indicate higher satisfaction with their current treatment), Year 1
|
| Locations: |
FDRC, Costa Mesa, California, 92627, United States|Scripps Whittier Diabetes Inst, La Jolla, California, 92037, United States|Reyes Clinical Research, Inc, Miami, Florida, 33175, United States|DC Research Works, Marietta, Georgia, 30060, United States|Urban Family Practice Assoc, Marietta, Georgia, 30067, United States|Macoupin Research Group, Gillespie, Illinois, 62033, United States|UnityPoint Health-Diabetes Care Center, Peoria, Illinois, 61603, United States|Endeavor Health, Skokie, Illinois, 60077, United States|Kernodle Clin Dpt-Pvt Diagnost, Burlington, North Carolina, 27215, United States|OnSite Clinical Solutions, LLC_Charlotte, Charlotte, North Carolina, 28277, United States|WakeMed Garner Hlthplx, Garner, North Carolina, 27529, United States|Clinical Research of Gastonia, Gastonia, North Carolina, 28054, United States|Valley Weight Loss Clinic, Fargo, North Dakota, 58104, United States|Diab & Endo Assoc of Stark Co, Canton, Ohio, 44718, United States|Central Ohio Clinical Research LLC, Columbus, Ohio, 43213, United States|Jefferson Endocrinology Assocs, Philadelphia, Pennsylvania, 19107-6810, United States|Tristar Clin Investigations, PC, Philadelphia, Pennsylvania, 19114, United States|Preferred Primary Care Physicians_Pittsburgh, Pittsburgh, Pennsylvania, 15236, United States|AnMed Health IMA, Anderson, South Carolina, 29621, United States|Baylor Scott & White Res Inst, Dallas, Texas, 75246, United States|Hill Country Medical Associates, New Braunfels, Texas, 78130, United States|DCT-Stone Oak, San Antonio, Texas, 78258, United States|Chrysalis Clinical Research, Saint George, Utah, 84790, United States
|
